Vericel to Present at the Canaccord Genuity Growth Conference on Wednesday, August 14, 2024
August 07 2024 - 7:30AM
Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies
for the sports medicine and severe burn care markets, today
announced that Nick Colangelo, President and CEO, will present at
the Canaccord Genuity Growth Conference at 3:00 p.m. ET on
Wednesday, August 14, 2024.
A webcast of the presentation will be available on the Investor
Relations section of the Vericel Corporation website at:
http://investors.vcel.com.
About Vericel Corporation
Vericel is a leading provider of advanced therapies for the
sports medicine and severe burn care markets. The Company combines
innovations in biology with medical technologies, resulting in a
highly differentiated portfolio of innovative cell therapies and
specialty biologics that repair injuries and restore lives. Vericel
markets three products in the United States. MACI® (autologous
cultured chondrocytes on porcine collagen membrane) is an
autologous cellularized scaffold product indicated for the repair
of symptomatic, single or multiple full-thickness cartilage defects
of the knee with or without bone involvement in adults. Epicel®
(cultured epidermal autografts) is a permanent skin replacement for
the treatment of patients with deep dermal or full thickness burns
greater than or equal to 30% of total body surface area. Vericel
also holds an exclusive license for North American rights to
NexoBrid® (anacaulase-bcdb), a biological orphan product containing
proteolytic enzymes, which is indicated for the removal of eschar
in adults with deep partial-thickness and/or full-thickness burns.
For more information, please visit www.vcel.com.
Epicel and MACI are registered trademarks of Vericel
Corporation. NexoBrid is a registered trademark of MediWound Ltd.
and is used under license to Vericel Corporation. © 2024 Vericel
Corporation. All rights reserved.
Investor Contact:Eric Burnsir@vcel.com+1 (734)
418-4411
Media Contact: Julie
Downsmedia@vcel.com
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Jul 2024 to Aug 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Aug 2023 to Aug 2024